Connection
Bryn Loutzenhiser to Humans
This is a "connection" page, showing publications Bryn Loutzenhiser has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.054 |
|
|
|
-
Lindley B, Bhakta Z, Leclair L, Young DC. The pharmacokinetics and pharmacodynamics of continuous infusion vancomycin in adult people with cystic fibrosis. Pediatr Pulmonol. 2024 Jan; 59(1):89-94.
Score: 0.022
-
Lindley B, Bhakta Z, Gray K, Watanabe A, Leclair L, Young DC. Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis. Pediatr Pulmonol. 2022 Nov; 57(11):2646-2651.
Score: 0.020
-
Yellepeddi VK, Lindley B, Radetich E, Kumar S, Bhakta Z, Leclair L, Parrot M, Young DC. Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis. Antimicrob Agents Chemother. 2024 01 10; 68(1):e0099223.
Score: 0.006
-
Killam-Worrall L, Brand R, Castro JR, Patel DS, Huynh K, Lindley B, Torres BP. Baclofen and Tizanidine Adverse Effects Observed Among Community-Dwelling Adults Above the Age of 50 Years: A Systematic Review. Ann Pharmacother. 2024 May; 58(5):523-532.
Score: 0.005